- Home
- ARBEW vs MRK Comparison
ARBEW vs MRK Comparison
Compare ARBEW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBEW | MRK |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 260.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARBEW | MRK |
|---|---|---|
| Price | $0.14 | $98.47 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $109.13 |
| AVG Volume (30 Days) | 32.4K | ★ 15.8M |
| Earning Date | 03-05-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | N/A | ★ 58.08 |
| EPS | N/A | ★ 7.56 |
| Revenue | $768,000.00 | ★ $64,235,000,000.00 |
| Revenue This Year | N/A | $1.97 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | ★ N/A | $13.27 |
| Revenue Growth | N/A | ★ 1.68 |
| 52 Week Low | $0.13 | $73.31 |
| 52 Week High | $1.25 | $105.84 |
Technical Indicators
Market Signals| Indicator | ARBEW | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 37.03 | 53.84 |
| Support Level | $0.13 | $96.06 |
| Resistance Level | $0.24 | $100.94 |
| Average True Range (ATR) | 0.03 | 2.33 |
| MACD | -0.00 | -0.70 |
| Stochastic Oscillator | 8.67 | 24.08 |
Price Performance
Historical ComparisonAbout ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).